FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2981868700> ?p ?o ?g. }

• W2981868700 endingPage "18099" @default.
• W2981868700 startingPage "18087" @default.
• W2981868700 abstract "A series of new quinazoline derivatives were designed and synthesized via a one-pot condensation reaction between isatoic anhydride and aromatic aldehydes with anilines using aluminum sulfate as a catalyst in refluxing ethanol. Their structures were confirmed by their physical, IR, 1H NMR, 13C NMR, and mass spectroscopy data and evaluated for some biological effects, including the antioxidant and α-glucosidase inhibitory activities as well as some in vivo hematological parameters. The ability of synthesized compounds in the inhibition of α-glucosidase was also investigated through the in silico study. The significant and important changes in some hematological tests were perceived. Notably, compound 4h showed more reducing effects on cholesterol and triglyceride levels. This molecule certainly has the potential to be developed as the antihyperlipemic compound. The tested compounds, in particular, compounds 4j and 4l, were found to be uniquely reducing blood sugar levels. The entire synthesized compounds showed the potent α-glucosidase inhibitory activity compared with acarbose as a standard material. Amongst, the compounds 4h and 4i showed the strongest enzyme inhibitory potentials than the standard drug acarbose. There was a good correlation between in vitro and in silico studies for ligands 4i and 4l. The majority of compounds presented a good radical scavenging activity, though the compound 4j exhibited the strongest activity, even to the standard of ascorbic acid. Further studies are required to determine whether these main compounds could be a potential treatment for diabetes and hyperlipidemia diseases." @default.
• W2981868700 created "2019-11-01" @default.
• W2981868700 creator A5054778839 @default.
• W2981868700 creator A5057645053 @default.
• W2981868700 creator A5060947705 @default.
• W2981868700 date "2019-10-25" @default.
• W2981868700 modified "2023-10-12" @default.
• W2981868700 title "Synthesis, Structural Studies, and α-Glucosidase Inhibitory, Antidiabetic, and Antioxidant Activities of 2,3-Dihydroquinazolin-4(1<i>H</i>)-ones Derived from Pyrazol-4-carbaldehyde and Anilines" @default.
• W2981868700 cites W1968841287 @default.
• W2981868700 cites W1969080191 @default.
• W2981868700 cites W1969288551 @default.
• W2981868700 cites W1982697144 @default.
• W2981868700 cites W1985846902 @default.
• W2981868700 cites W1987100555 @default.
• W2981868700 cites W1987753836 @default.
• W2981868700 cites W1991735918 @default.
• W2981868700 cites W1999647730 @default.
• W2981868700 cites W2004962991 @default.
• W2981868700 cites W2006859302 @default.
• W2981868700 cites W2013872708 @default.
• W2981868700 cites W2018072827 @default.
• W2981868700 cites W2018356077 @default.
• W2981868700 cites W2031092183 @default.
• W2981868700 cites W2033265076 @default.
• W2981868700 cites W2039743198 @default.
• W2981868700 cites W2041361567 @default.
• W2981868700 cites W2041499625 @default.
• W2981868700 cites W2044242984 @default.
• W2981868700 cites W2055160702 @default.
• W2981868700 cites W2055190998 @default.
• W2981868700 cites W2057600950 @default.
• W2981868700 cites W2066659788 @default.
• W2981868700 cites W2068052959 @default.
• W2981868700 cites W2072852680 @default.
• W2981868700 cites W2088459933 @default.
• W2981868700 cites W2098170575 @default.
• W2981868700 cites W2113443590 @default.
• W2981868700 cites W2114602038 @default.
• W2981868700 cites W2114726424 @default.
• W2981868700 cites W2120538914 @default.
• W2981868700 cites W2133822451 @default.
• W2981868700 cites W2134879756 @default.
• W2981868700 cites W2139277690 @default.
• W2981868700 cites W2148427775 @default.
• W2981868700 cites W2150646573 @default.
• W2981868700 cites W2161849974 @default.
• W2981868700 cites W2163140898 @default.
• W2981868700 cites W2169532593 @default.
• W2981868700 cites W2171587695 @default.
• W2981868700 cites W2179628549 @default.
• W2981868700 cites W2179778080 @default.
• W2981868700 cites W2282002527 @default.
• W2981868700 cites W2326833342 @default.
• W2981868700 cites W2337557492 @default.
• W2981868700 cites W2400558897 @default.
• W2981868700 cites W2408113388 @default.
• W2981868700 cites W2416663924 @default.
• W2981868700 cites W2462801118 @default.
• W2981868700 cites W2519485652 @default.
• W2981868700 cites W2548888062 @default.
• W2981868700 cites W2552966031 @default.
• W2981868700 cites W2569797875 @default.
• W2981868700 cites W2593609694 @default.
• W2981868700 cites W2610973288 @default.
• W2981868700 cites W2725743431 @default.
• W2981868700 cites W2747978406 @default.
• W2981868700 cites W2749765852 @default.
• W2981868700 cites W2770796289 @default.
• W2981868700 cites W2789360233 @default.
• W2981868700 cites W2790161043 @default.
• W2981868700 cites W2790258163 @default.
• W2981868700 cites W2791378650 @default.
• W2981868700 cites W2793995337 @default.
• W2981868700 cites W2896855747 @default.
• W2981868700 cites W2908836818 @default.
• W2981868700 cites W2921438763 @default.
• W2981868700 cites W2938717569 @default.
• W2981868700 cites W2951167417 @default.
• W2981868700 cites W331458653 @default.
• W2981868700 cites W4246384439 @default.
• W2981868700 doi "https://doi.org/10.1021/acsomega.9b01906" @default.
• W2981868700 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6843711" @default.
• W2981868700 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31720511" @default.
• W2981868700 hasPublicationYear "2019" @default.
• W2981868700 type Work @default.
• W2981868700 sameAs 2981868700 @default.
• W2981868700 citedByCount "26" @default.
• W2981868700 countsByYear W29818687002020 @default.
• W2981868700 countsByYear W29818687002021 @default.
• W2981868700 countsByYear W29818687002022 @default.
• W2981868700 countsByYear W29818687002023 @default.
• W2981868700 crossrefType "journal-article" @default.
• W2981868700 hasAuthorship W2981868700A5054778839 @default.
• W2981868700 hasAuthorship W2981868700A5057645053 @default.
• W2981868700 hasAuthorship W2981868700A5060947705 @default.
• W2981868700 hasBestOaLocation W29818687001 @default.
• W2981868700 hasConcept C150903083 @default.
• W2981868700 hasConcept C178790620 @default.

• next